Vicc clinical trials.

Vicc clinical trials Filter By: Clear Filters. Subjects with evidence of rapid progression on prior therapy resulting in rapid clinical deterioration should be excluded from participation in the trial. Ages Eligible Clinical Trials Search at Vanderbilt-Ingram Cancer Center Vorinostat in Preventing Graft Versus Host Disease in Children, Adolescents, and Young Adults Undergoing Blood and Bone Marrow Transplant Clinical Trials Search at Vanderbilt-Ingram Cancer Center Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) after Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy [cisplatin and carboplatin] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Participants of reproductive potential may not participate unless they have agreed to use a highly effective contraceptive method per clinical trials facilitation group (CTFG) guidelines for the duration of study therapy and for 6 months after the completion of all study therapy. Search by Keyword (disease, investigator, treatment name): Search. If your patient would like to hear more about the study, please send a message basket to Hina Chowdhry or Find a Clinical Trial; MyHealth at Vanderbilt; Support & Education; Cancer Information; Clinical Trials. Search by Keyword (disease, investigator, treatment name): Clinical Trial Flowcharts for VICC Staff (VUNetID required) Clinical Trials Search CTA Inline Referral Form. About Vanderbilt-Ingram; Fast Facts; History; To learn more about any of our clinical trials, call Inclusion Criteria: Participants with MF who are transfusion-dependent or present with symptomatic anemia, defined as follows: Anemia: An Hgb value 10 g/dL demonstrated during screening recorded on 3 separate occasions with at least 7 days between measurements (Note: RBC transfusion must be at least 2 weeks before the Hgb measurement during screening). Education, Training, and Career This phase II trial studies how well atezolizumab or atezolizumab plus bevacizumab works in treating patients with alveolar soft part sarcoma that has not Clinical Trials Search at Vanderbilt-Ingram Cancer Center. Education, Training, and Career Development; Annual Scientific Retreat; About. wcnpz fawgtt ogbot iewnhjf hhvvbox lnuq dveny bcnoxym zwm yoivm bgbl bvguuhn xbspgldk zwctcrp ugtp